Research depth: With over 30 years of published research, GHRP-6 has the most extensive evidence base of any GH secretagogue
It's all about metabolic health
The pattern typically looks like this: diarrhea appears or worsens within first few days after a dose increase, lasts for several days to a couple of weeks, and then settles as body adjusts
The oral switch data is also important
For patients approaching major milestones, the Wegovy first month results and Zepbound before and after articles offer useful context for how different patients experience the full arc of treatment from early stages through significant loss
3 MASLD is now the most prevalent chronic liver disease in the world, encompassing a continuum of liver abnormalities from MASLD to metabolic dysfunction-associated steatohepatitis (MASH), progressing to cirrhosis and hepatic cancer